Efficiency of Prevention Program Dedicated to Addictive Behaviors

Status Recruiting

Clinical Trial Summary

At the age of 17, in Brittany, 94.9% of adolescents have experimented alcohol consumption 78.1% within a month and 25.5% report repeated episodes of Intensive Punctual Alcohol. Among the potential explanatory factors of this worrying epidemiology, social and cultural factors induce a social valuation of alcohol consumption and drunkenness. There are also individual vulnerability factors, particularly important in adolescence between experimentation and the transition to regular use or even to alcohol use disorders. Despite the extent of the damage, there is currently little reliable data on effective primary prevention strategies for dealing with addictive behavior. Many prevention programs target age range in school settings, to delay or reduce use of psychoactive substances. A meta-analysis on the impact of this prevention programs in school settings, concluded that most interventions are associated with no or little impact with respect to the goal of reducing psychoactive substances with teenagers. Among existing programs, "PREVENTURE" has been evaluated in 5 trials with high-risk teenagers identified in schools settings, in different countries (Canada, Europe). The results show a clear and robust effect on reducing alcohol consumption. This program has not been tested outside the school setting and a recent review mention the need to make this program more accessible by targeting vulnerable groups and studying the impact of this program on this population. The PREVADO study is a prospective, controlled, randomised, open-label study. After inclusion, the adolescent completes the questionnaire SURPS (Substance Use Risk Profile Scale). The SURPS is self-report questionnaire that assesses four well-validated personality risk factors for substance misuse (Impulsivity, Sensation Seeking, Anxiety Sensitivity, and Hopelessness). There is a 23-item to which adolescents are asked to respond using a 4-point Likert scale ranging from "strongly agree" to "strongly disagree" : Hopelessness (7 items), Anxiety Sensitivity (5 items), Impulsivity (5 items), and Sensation Seeking (6 items). Adolescents will be randomized into 2 groups (stratification on the 4 predominant risk personality types from the SURPS (Substance Use Risk Profile Scale) and on the recruitment modality) : - Intervention group : teenagers follow the "PREVENTURE" program and routine cares - Control group : teenagers follow routine cares

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04599270
Study type	Interventional
Source	University Hospital, Brest
Contact	Morgane GUILLOU - LANDREAT, Dr
Phone	029822342348
Email	morgane.guillou@chu-brest.fr
Status	Recruiting
Phase	N/A
Start date	October 1, 2021
Completion date	October 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04876443` - Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD)
Recruiting	`NCT05042180` - Virtual Reality-Assisted Cognitive Behavioral Therapy for Alcohol Dependence (CRAVR)	Phase 2
Recruiting	`NCT05361603` - Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Recruiting	`NCT04990765` - Virtual Reality-Assisted Cognitive Behavioral Therapy for Alcohol Dependence (CRAVR-Pilot)	Phase 2
Recruiting	`NCT05730504` - Evaluating the Effectiveness of Mobile Self-guided Psychological Interventions to Reduce Relapse in Substance Use Disorder	N/A
Recruiting	`NCT05434416` - The Efficacy of a Mobile Application in Reducing Craving and Lapse Risk in Alcohol and Stimulants Problematic Use	N/A
Not yet recruiting	`NCT05134675` - Does Homebrewing Beer Affect Urinary Tract Symptoms and Bladder Cancer
Completed	`NCT06114316` - Recovery of Individuals With Alcohol Use Disorders Based on Roy Adaptation Model	N/A
Recruiting	`NCT05322226` - Addiction Intervention in Liver Transplantation Candidates	N/A
Terminated	`NCT04881500` - Impact of a Brief Motivational Intervention Including Counter-marketing Arguments With a Population of Patients With Moderate to Severe Alcohol Use Disorders Who Are Followed up on an Outpatient Basis (Primary Care or Addictology) (DEPREV_Phase 3)	N/A
Recruiting	`NCT05490589` - Evaluation of the Implementation of a Parenting Program in Parents With Children Aged 4 to 12 Years and One Parent With an Alcohol Use Disorders	N/A
Recruiting	`NCT06105853` - Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder	N/A
Completed	`NCT03232112` - Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?	Phase 2
Active, not recruiting	`NCT04927455` - Pilot Study to Evaluate "Intégrer et Accompagner Les Consommations d'Alcool!" (IACA!)'s Impact and Transferability

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Efficiency of Prevention Program Dedicated to Addictive Behaviors (PREVENTURE) of Vulnerable Teenagers — PREVADO

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms